SCHEMBL19626490

SCHEMBL19626490

Cc1nc(-c2ccc(NC(=O)C(C)(C)C)cc2)cs1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 16/20 0.67
▸ NPC1 O15118 15/20 0.67
▸ SMN1; SMN2 Q16637 7/20 0.67
▸ ALDH1A1 P00352 5/20 0.64
▸ KDM4E B2RXH2 3/20 0.64
▸ MAPT P10636 3/20 0.64
▸ NFKB1 P19838 2/20 0.64
▸ NFKB2 Q00653 2/20 0.64
▸ RELA Q04206 2/20 0.64
▸ MEN1 O00255 4/20 0.61
▸ KMT2A Q03164 4/20 0.61
▸ HPGD P15428 3/20 0.61
▸ PKM P14618 2/20 0.61
▸ STAT1 P42224 2/20 0.61
▸ TP53 P04637 2/20 0.61
▸ MAPK1 P28482 1/20 0.61
▸ RXFP1 Q9HBX9 1/20 0.61
▸ TDP1 Q9NUW8 1/20 0.61
▸ HSD17B10 Q99714 1/20 0.61
▸ GFER P55789 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19625312 0.87 RAB9A (0.59) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL19267603 0.84 RAB9A (0.72) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL19627035 0.82 RAB9A (0.70) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL16404739 0.78 RAB9A (0.85) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL14199780 0.78 RAB9A (0.71) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL16217072 0.78 RAB9A (1.00) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL27885076 0.78 NFKB1 (1.00) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL19625304 0.74 KMT2A (0.61) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL17626115 0.74 NPC1 (0.60) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL14553224 0.74 NPC1 (0.78) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 RAB9A 3162/4885NPC1 2489/4885SMN1; SMN2 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback